FDA to decide on Pfizer’s RSV vaccine by May



Pfizer Inc. confirmed on Wednesday that the United States Food and Drugs Administration (FDA) accepted to review its RSV vaccine candidate, with the final decision expected by May next year.

The vacc…

About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento